Expression of β2‐adrenergic receptor in oral squamous cell carcinoma
Authors:
- 20 March 2009
- journal article
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 38 (4) , 371-376
Abstract
Background: It has been speculated that chemokines and neurotransmitters might be involved in the organ‐specific development of metastases because cancer metastasis is similar to the regulation of migratory activity in leukocytes. Here, we aimed to examine the expression of β2‐adrenergic receptor (β2‐AR) in oral squamous cell carcinoma (OSCC), and to investigate its correlation with tumor development and metastasis.Methods: Expression of β2‐AR was examined in 65 cases of OSCC specimens, 10 cases of normal oral mucosa, and two cell lines using immunohistochemistry, Western blot and RT‐PCR. The differences in β2‐AR expression between various groups were evaluated using SPSS 13.0 Statistical Software. Cell proliferation assays were assayed by β‐adrenergic receptors agonists (norepinephrine) and antagonists (propranolol). Norepinephrine‐mediated cell migration was assayed in Matrigel‐coated chemotaxis chamber.Results: β2‐AR was highly expressed on OSCC compared to normal controls. In OSCC, positive β2‐AR expression was significantly correlated with cervical lymph node metastasis (P = 0.001), age (P = 0.003), tumor size (P = 0.001) and clinical stage (P = 0.001), but not with gender. RT‐PCR and Western blot also confirmed positive β2‐AR expression in OSCC and TCa8113 cell line, and negative β2‐AR expression in normal oral mucosa and ACC cell line. β‐adrenoreceptor agonist (norepinephrine) was a potent mitogen for TCa8113 and ACC cell lines, and completely inhibited by the selective antagonist of β‐adrenergic receptors (propranolol). Norepinephrine induced migratory activity of OSCC cells in a dose‐dependent manner.Conclusion: Increased expression of β2‐AR may play an important role in the formation and metastasis of OSCC.Keywords
This publication has 18 references indexed in Scilit:
- Suppression of salivary adenoid cystic carcinoma growth and metastasis by ErbB3 binding protein Ebp1 gene transferInternational Journal of Cancer, 2007
- Growth suppression induced by Notch1 activation involves Wnt—β‐catenin down‐regulation in human tongue carcinoma cellsBiology of the Cell, 2006
- The norepinephrine‐driven metastasis development of PC‐3 human prostate cancer cells in BALB/c nude mice is inhibited by β‐blockersInternational Journal of Cancer, 2006
- Expression of CXCR4 and Its Down-Regulation by IFN-γ in Head and Neck Squamous Cell CarcinomaClinical Cancer Research, 2005
- Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugsInternational Journal of Cancer, 2004
- Chemokines and the Molecular Basis of Cancer MetastasisNew England Journal of Medicine, 2001
- The role of chemoattraction in cancer metastasesBioEssays, 2001
- Chemokines — Chemotactic Cytokines That Mediate InflammationNew England Journal of Medicine, 1998
- Direct Innervation of Lymphoid Organs: Substrate for Neurotransmitter Signaling of Cells of the Immune SystemNeuropsychobiology, 1993
- Cell type specific, receptor-mediated modulation of growth kinetics in human lung cancer cell lines by nicotine and tobacco-related nitrosaminesBiochemical Pharmacology, 1989